A message from the President of MASCC

Dear Colleagues,

I’m pleased to announce that MASCC/ISOO 2021 — the next joint meeting of the Multinational Association of Supportive Care in Cancer (MASCC) and the International Society of Oral Oncology (ISOO) — will be held in Seville, Spain from June 24 to 26, 2021.

I would like to personally invite you to join us at the 2021 meeting, which annually brings together world experts to share the newest advances in managing the symptoms and side effects of cancer and its treatments. This year’s meeting themes include cardio-oncology, bioethics, and models of supportive care, as well as digital health, palliative care, and cancer survivorship. The meeting also highlights new treatments and technologies for minimizing the effects of the latest cancer treatments — cytotoxic treatments, targeted therapies, and immunotherapies.

Professionals and trainees from diverse fields will share their knowledge and collaborate on the best new practices to improve supportive care and quality of life for people with cancer. The meeting will feature plenary and parallel sessions, multidisciplinary workshops, meet-the-expert sessions, e-posters, and social events.

MASCC/ISOO 2021 promises a cutting-edge scientific program and offers a tremendous opportunity to share your latest developments and grow awareness of supportive cancer care with health professionals from around the world.

We look forward to seeing you in Seville!

Rajesh V. Lalla,
MASCC President

MASCC President Rajesh V. Lalla, DDS, PhD, is a Professor of Oral Medicine and Associate Dean for Research at the University of Connecticut (UConn), Farmington, Connecticut, USA. Actively involved in clinical care, teaching, and research, he specializes in oral complications of cancer therapy. Dr. Lalla has served on MASCC’s Board of Directors since 2012 and is the first non-physician to serve as MASCC President. Dr. Lalla is a past Chair of the MASCC Mucositis Study Group, where he led the development and publication of the 2014 MASCC/ ISOO Clinical Practice Guidelines for the Management of Mucositis Secondary to Cancer Therapy.


MASCC, founded in 1990, is recognized as the world leader in supportive cancer care with an international and multidisciplinary membership that includes high-level oncology clinicians and research scientists, including medical, surgical, and radiation oncologists, dentists, pharmacists, psychologists, nurses, and other professionals in supportive cancer care from more than 70 countries. MASCC maintains 16 active Study Groups that conduct research, design educational materials, and develop internationally recognized practice guidelines. Current Study Groups, led by world experts, include the fields of Antiemetics, Bone and Musculoskeletal Issues, Education, Fatigue, Geriatrics, Hemostasis, Mucositis, Neurological Complications, Neutropenia, infection and Myelosuppression, Nutrition and Cachexia, Oncodermatology, Oral Care, Palliative Care, Pediatrics, Psychosocial Issues, and Survivorship.

MASCC is also the umbrella association for affiliates organizations, such as the Association Francophone des Soins Oncologiques de Support (AFSOS), the Indian Association of Supportive Care in Cancer (IASCC), the Network Italiano Cure di Supporto in Oncollogia (NICSO), and the Russian Society of Supportive Care in Oncology (RASSC). In addition to its partnership with the ISOO, MASCC maintains partnership agreements with the Oncology Nursing Society (ONS), the European Oncology Nursing Society (EONS), The European Society for Medical Oncology (ESMO), the International Society of Nurses in Cancer Care (ISNCC), and the International Society of Geriatric Oncology (SIOG).

What is Supportive Care?

Supportive Care in cancer is the prevention and management of the adverse effects of cancer and its treatment. This includes management of physical and psychological symptoms and side effects across the continuum of the cancer experience: from diagnosis, through treatment, to post-treatment care. Enhancing rehabilitation, secondary cancer prevention, survivorship, and end-of-life care are integral to supportive care.

Benefits of Supportive Care

  • Alleviation of symptoms and complications of cancer
  • Prevention or reduction of treatment toxicities
  • Improved communication between patients and caregivers
  • Increased tolerance, and thus benefits, of active therapy
  • Easing of the emotional burden for patients and caregivers
  • Psychosocial support for cancer survivors

The MASCC Journal: Supportive Care in Cancer

The official journal of MASCC is Supportive Care in Cancer. Here you can read about the latest advances in management of symptoms and side effects of cancer therapies, as well as numerous other aspects of supportive care for patients, their families, and caregivers.

Supportive Care in Cancer

MASCC Guidelines and Tools

Through its Study Groups, MASCC has produced a wealth of guidelines and tools, including Mucositis and Antiemetic practice guidelines, assessment tools, and apps. See our Practice Resources page for the latest workshops, books, and other supportive care links.

Practice Resources

MASCC Study Groups and Research

Our 16 Study Groups are the lifeblood of MASCC and offer a way for MASCC members to participate in an international community of researchers and clinicians. Study Groups work together to conduct literature reviews, surveys, research, and practice guidelines.

Study Groups